More Than Active Ingredients

Two products can contain the same active ingredient at the same concentration and still perform very differently.

Solubility, physical state, stability, compatibility and the formulation environment all influence what ultimately happens to an active ingredient.

The relevant question is therefore not only what is in the formula, but how that ingredient exists within the finished formulation.

What We Consider in Every Formulation

  • Solubility

    Is the active genuinely dissolved or appropriately incorporated within the formulation?

  • Stability

    Does the active and the surrounding formulation architecture remain stable throughout product life?

  • Vehicle Architecture

    What physical and chemical environment surrounds the active, and how might that influence release and application?

  • Tolerability

    Is the finished treatment comfortable and practical enough to support consistent use?

The Delivery Vehicle Matters

A formulation is not an inert container for active ingredients.

Phase structure, solvent environment, surfactants, oils, rheology, spreading and post-application changes can all influence how an active is presented to the skin or scalp.

For difficult-to-formulate actives, vehicle architecture can therefore become an important part of the performance equation.

Stability + Tolerability

  • Stability Is a Performance Requirement

    A formulation cannot deliver its intended performance if its active ingredients degrade, crystallise or become unavailable during storage.

    We therefore treat physical and chemical stability as part of formulation performance—not merely shelf life.

  • Tolerability Influences Real-World Performance

    A technically sophisticated product has limited value if it is unpleasant or impractical to use.

    Sensory quality, spreadability and tolerability are therefore functional formulation variables.

Formulation Architecture Before Ingredient Fashion

We begin with the treatment objective and then determine the formulation environment required to support the relevant actives.

The objective is not to maximise every ingredient concentration. It is to create a coherent system in which the components work together.

Evidence Should Follow the Finished Formulation

Published research on an ingredient provides important biological rationale, but it does not automatically establish the performance of every finished product containing that ingredient.

As a claim becomes more specific to the finished treatment, the evidence supporting it should become more formulation-specific.

We therefore view cosmetic evidence as a progression—from ingredient rationale and formulation characterisation through to product-specific testing and controlled substantiation.